Literature DB >> 28837381

Dermal filler-associated malar edema: Treatment of a persistent adverse effect.

Shawn M Iverson1, Rakesh M Patel1.   

Abstract

A 72-year-old Caucasian female presented for evaluation of bilateral lower eyelid "fluid filled" bags that had been present and slowly worsening for 7 years. She reported a history of lower eyelid blepharoplasty in her 40s, as well as hyaluronic acid tear trough fillers 8 years prior to presentation. Her malar edema completely resolved following injection of hyaluronidase. To our knowledge, this is the longest reported interval for presentation and treatment of hyaluronic acid associated malar edema.

Entities:  

Keywords:  Hyaluronic acid; complications; dermal filler; malar edema

Mesh:

Substances:

Year:  2017        PMID: 28837381     DOI: 10.1080/01676830.2017.1337203

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  4 in total

1.  Hyaluronic Acid Gel Injection for the Treatment of Tear Trough Deformity: A Multicenter, Observational, Single-Blind Study.

Authors:  Alberto Diaspro; Lucia Calvisi; Giuseppe Sito
Journal:  Aesthetic Plast Surg       Date:  2022-04-27       Impact factor: 2.708

2.  A Case of Orbital Granuloma Secondary to Dermal Filler Injection.

Authors:  Stephen C Dryden; Ryan D Gabbard; Andrew G Meador; Alison E Stoner; Kimberly A Klippenstein; Ralph E Wesley
Journal:  Cureus       Date:  2021-12-22

3.  Intralesional Tetracycline Injection, Pinch Technique, and Canthopexy for the Treatment of Severe Festoons: Preliminary Results.

Authors:  Sergio Lessa; João Pontello; Deilton Duarte; Diogo Lobão
Journal:  Aesthet Surg J Open Forum       Date:  2021-11-20

4.  Evaluation of Adverse Effects of Resorbable Hyaluronic Acid Fillers: Determination of Macrophage Responses.

Authors:  Wim H De Jong; Danyel Jennen; Peter H J Keizers; Hennie M Hodemaekers; Jolanda P Vermeulen; Frank Bakker; Paul Schwillens; Marcel van Herwijnen; Marlon Jetten; Jos C S Kleinjans; Robert E Geertsma; Rob J Vandebriel
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.